Editorial || FREE PAPER ||

Garry Walsh

Asthmatic and Allergic Inflammation Group, School of Medicine, University of Aberdeen, UK

Welcome to the first issue of Therapeutics and Clinical Risk Management – a new international peer-reviewed journal. As the title suggests, the journal will publish original research and review articles on the evidence and opinion behind new and existing therapies. A further aim will be to define the usage of these therapies in terms of ultimate uptake and acceptance by the patient and healthcare professional. This is an area that to date has been somewhat neglected, and Dove Medical Press are to be congratulated for the launch of a new title that addresses these vital issues in an era when evidence-based medicine is becoming ever more important. The remit of the journal will of necessity be a broad one and, in this respect, represents a considerable challenge to all involved.